Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, with Merit Medical (MMSI) identified as a strong candidate due to its favorable growth metrics and Zacks Rank [2][10]. Group 1: Earnings Growth - Merit Medical has a historical EPS growth rate of 21.5%, with projected EPS growth of 11.2% for the current year, surpassing the industry average of 10% [4]. - The company’s strong earnings growth is a key factor attracting investor interest, particularly for growth investors who favor double-digit growth rates [3]. Group 2: Cash Flow Growth - Merit Medical's year-over-year cash flow growth stands at 12.2%, significantly higher than the industry average of -2% [5]. - The historical annualized cash flow growth rate for the company is 11.5% over the past 3-5 years, compared to the industry average of 2% [6]. Group 3: Earnings Estimate Revisions - The current-year earnings estimates for Merit Medical have been revised upward, with the Zacks Consensus Estimate increasing by 0.5% over the past month [8]. - Positive trends in earnings estimate revisions are correlated with near-term stock price movements, indicating strong potential for the company [7]. Group 4: Overall Assessment - Merit Medical has achieved a Growth Score of B and a Zacks Rank of 2, reflecting its strong growth potential and positive earnings estimate revisions, making it a solid choice for growth investors [10].
Looking for a Growth Stock? 3 Reasons Why Merit Medical (MMSI) is a Solid Choice